LYTIR

Insider · SEC Form 4 · Chief Medical Officer

Rodman David Malcom

In the 12 months to Nov 8, 2026, on the open market: sold $1.0M of MLYS. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $1.0M in total.Jun: Insider sales $350KJul: Insider sales $633KAug: Insider sales $59KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $1.0M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. MLYSSold: Mineralys Therapeutics, Inc. Aug 10, 2026 2,170 shares filed Aug 12, 2026 51,384 shares held directly after, as filed 10b5-1 plan filing $59K
  2. MLYSSold: Mineralys Therapeutics, Inc. Jul 17, 2026 416 shares filed Jul 20, 2026 51,384 shares held directly after, as filed 10b5-1 plan filing $11K
  3. MLYSSold: Mineralys Therapeutics, Inc. Jul 15, 2026 6,349 shares filed Jul 15, 2026 51,384 shares held directly after, as filed 10b5-1 plan filing $169K
  4. MLYSSold: Mineralys Therapeutics, Inc. Jul 13, 2026 14,058 shares filed Jul 15, 2026 57,733 shares held directly after, as filed 10b5-1 plan filing $388K
  5. MLYSSold: Mineralys Therapeutics, Inc. Jul 9, 2026 2,171 shares filed Jul 10, 2026 57,733 shares held directly after, as filed 10b5-1 plan filing $66K
  6. MLYSSold: Mineralys Therapeutics, Inc. Jun 17, 2026 4,584 shares filed Jun 17, 2026 57,095 shares held directly after, as filed 10b5-1 plan filing $115K
  7. MLYSSold: Mineralys Therapeutics, Inc. Jun 15, 2026 9,890 shares filed Jun 17, 2026 57,095 shares held directly after, as filed 10b5-1 plan filing $235K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • MLYS: option exercise or conversion (code M), 9 entries, Jun 15 to Aug 10, 2026
Code M
An exercise or conversion of a derivative security received from the company, such as stock options.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.